SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia is currently trending due to strong commercial momentum for Yutrepia, which is outpacing competitors in the PAH and PH-ILD space, while investors eagerly await a long-anticipated court ruling regarding ongoing patent litigation. The community is actively debating the stock's significant multi-year performance and potential acquisition prospects versus the inherent risks associated with the unresolved legal bottleneck.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is experiencing significant volatility driven by intense speculation around a potential short squeeze, as community members highlight high short interest and aggressive options activity despite ongoing concerns over cash burn and recent financial restructuring. Investors remain divided, with some betting on long-term growth from AI data center and silicon carbide adoption, while others warn of dilution risks and the company's challenging historical financial performance.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

Abbott Laboratories is experiencing significant volatility driven by a mixed earnings report and ongoing investor debate regarding the company's valuation following its acquisition of Exact Sciences. While the community is split between those viewing the pullback as a buying opportunity in a defensive healthcare leader and those expressing frustration over recent price declines, active traders are closely monitoring key support levels and the stock's potential for a long-term rebound.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is facing significant community frustration as shareholders express dissatisfaction with leadership's capital allocation and a stagnant stock price despite recent earnings beats. Investors are closely monitoring the company's oncology pipeline and potential M&A activity to address looming patent cliffs, while some traders explore hedging strategies amidst ongoing volatility.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund ($XLE) is currently trending as investors navigate extreme volatility and sector rotation fueled by ongoing geopolitical tensions in the Strait of Hormuz. While some participants are betting on a recovery through call options amid speculation about a potential ceasefire and normalization of shipping routes, others remain focused on the structural supply deficit and depleted global energy inventories that continue to support a bullish long-term outlook for the energy sector.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is currently under intense scrutiny as investors weigh its AI-driven growth trajectory, particularly in cloud and autonomous driving, against broader concerns regarding geopolitical tensions and regulatory risks for Chinese ADRs. The community is actively debating the stock's long-term valuation in light of recent chip unit IPO rumors, while navigating high volatility fueled by speculative options trading and conflicting sentiment over macroeconomic stability.

TOSHI

TOSHI is trending as investors speculate on potential ecosystem developments and community-led initiatives, with many participants actively accumulating tokens in anticipation of future growth. Discussion centers around technical consolidation, upcoming project updates, and a strong community sentiment focused on the potential for a significant market move.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is facing significant volatility as investors weigh aggressive inflows driven by the AI-linked memory supercycle against risks from leveraged ETF unwinding and geopolitical concerns. While the fund remains a popular proxy for semiconductor leaders like SK Hynix and Samsung, community sentiment is currently polarized between those viewing current pullbacks as accumulation opportunities and others warning of a potential structural bubble.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is experiencing significant market volatility driven by investor speculation over pending insurance coverage decisions and the competitive threat from rival needle-free treatments. The community remains deeply divided, with discussions centered on high short interest, the company's aggressive commercial spending, and diverging outlooks on the potential for institutional accumulation versus long-term financial viability.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is currently at the center of a heated community debate, with bulls advocating for a potential squeeze while skeptics warn of ongoing price consolidation and future downside risk. Traders remain deeply divided, as the conversation cycles between speculative accumulation in the hope of future rallies and intense criticism from those who view the coin as a long-term dilution risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is WisdomTree U.S. MidCap ETF (EZM) a Strong ETF Right Now?

Corporate Profits Climb to Fresh Highs: ETFs in Focus 

Record corporate profits and elevated margins put earnings-focused ETFs like EPS, EZM and EES in the spotlight.

Should WisdomTree U.S. MidCap ETF (EZM) Be on Your Investing Radar?

WisdomTree Trust - WisdomTree U.S. MidCap Fund

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

EZMWisdomTree Trust - WisdomTree U.S. MidCap Fund

Fundamentals

Latest EZM News